Pancreatic Cancer Research

ResearcherUniversité Paris CitéNo recent work listed

Mathilde Wisniewski

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0004-0992-8718; OpenAlex author ID A5073533506. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 1 paper

Papers 2

  1. Maintenance therapies in metastatic pancreatic cancer: present and future with a focus on PARP inhibitors. Co-author DOI 10.1177/1758835920937949↗
  2. Adjuvant chemotherapy with gemcitabine plus erlotinib vs. gemcitabine alone for patients with resected pancreatic ductal adenocarcinoma: is there a role for er… Co-author DOI 10.21037/hbsn.2018.08.03↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Pascal R. Hammel · 2 shared papers, 2018–2020 · strength 0.19
  2. Christelle d’Engremont · 1 shared paper, 2020 · strength 0.11
  3. Carole Vitellius · 1 shared paper, 2020 · strength 0.11
  4. Cindy Neuzillet · 1 shared paper, 2020 · strength 0.11
  5. Anthony Turpin · 1 shared paper, 2020 · strength 0.11
  6. Émeric Boisteau · 1 shared paper, 2020 · strength 0.11
  7. Marc Hilmi · 1 shared paper, 2020 · strength 0.11
  8. Louis de Mestier · 1 shared paper, 2020 · strength 0.11
  9. Michele Lamuraglia · 1 shared paper, 2018 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.